Essential Ally is an IP strategy and service provider and offers innovative and practical solutions to complex IP and regulatory matters in view of client goals. Identify, protect, defend, and monetize new and existing technology through effective business-oriented IP strategies. Client industries include: Pharmaceutical, Biotechnology, Agricultural and Chemical. Clients range from small start-ups to multi-national companies. Led company revenue growth of 35% and customer growth of 25% year over year. Servicing a full range of clients in the pharma, biotech, chemical and industrial sectors.Pharmaceutical | Biotechnology | Agriculture | Medical Device | Formulation Technology Patent Law | Hatch-Waxman Law | IP Business Strategy/Development• Intellectual property strategy, global portfolio management, preparation and prosecution (patents and trademarks); technology areas: small molecule chemistry, biologics, bacterial products, industrial chemicals, agricultural chemicals and biologics, API manufacturing, and formulation technology, including nanotechnology.• IP opinion work including landscape review, white space mapping, freedom-to-operate, validity and patentability assessments. • Food and drug law strategy and litigation support (Hatch-Waxman, pharmaceuticals, biologics, and medical device)• Intellectual property related mergers and acquisition support • Intellectual property related business development transactions and strategy support (due diligence, licensing, asset sale and acquisition, joint development and collaboration agreements, etc.)• IP training and coachingEXPERIENCE: Leadership, Alliance Management, P&L, Business Development, Sales and Marketing, Business Accounting and Taxation, Small Business Start-up, IP Strategy

Nonprofit organization that advances and connects women in technology, law and policy. The organization accelerates innovation through diversity of thought, participation, and engagement. As a steering committee member support, determine, organize, and implement organizational outreach, participation, and engagement events.EXPERIENCE: Event Planning, Marketing, Diversity Outreach

Affinity group within the Diversity and Inclusion Department of FMC Corporation dedicated to raising the profile of women at FMC by fostering wellbeing, education, development, and networking in the workplace. Developed monthly newsletter highlighting and raising the profile of women within FMC, organized internal and external events advancing the skills, networking, and development of women of FMC. EXPERIENCE: Leadership, Emotional Quotient (EQ) Advancement, Corporate Board Initiative, Sustainability within D&I, Coaching, Management, Mentoring, Gender Empowerment

Global agricultural company invested in discovering new active ingredients, innovative formulations, and biologics to advancing agricultural technologies that support sustainable agriculture around the world. Led the IP department for the Agricultural Division of FMC. Managed team of global professionals and multi-million dollar budget. Managed and supported a diverse portfolio of legal matters impacting the global Agriculture Solutions business, including strategic business planning, cross-functional project team member and leader, intellectual property (IP), technology transactions, mergers and acquisitions, licensing, alliance management, litigation, regulatory matters, and company policies.EXPERIENCE: IP Strategy, IP Portfolio Development and Management, IP Portfolio Maintenance and Review, International IP Strategy, Due Diligence, Technology Transactions, M&A, New Venture IP Strategy and Mapping, Competitive Landscaping, Asset Monetizing Strategies, Know-How Protection Strategy, Trademarks, Litigation at ITC and District Court, Arbitration, Import/Export Compliance, Employee IP rights and compensation, Non-Compete Agreements, EPA Regulation, Patent Presenter and Panelist, People Management, Budget Management, Cross-Border Enforcement, R&D Vision and Thought Leadership, and Senior Level Leadership and Management.

Professional organization serving in-house counsel in the Greater Philadelphia region, the Lehigh Valley, Southern New Jersey, and Delaware. Award-winning ("Large Chapter of the Year" and "Member Excellence") Chapter with membership exceeding 1,600. Provides CLEs, social, referrals and networking opportunities. Committee Chair for the Health, Biotech and Pharma Committee (2012-2018). Committee Chair for Law Student Outreach Initiative (2012-2015).

Leader in the complex science behind a wide variety of healthcare products, including active pharmaceutical ingredient (API) development and manufacture, solid form science and particulate engineering, catalysts and intermediates, and precision components for medical devices. Supported business development professionals in navigating the competitive intellectual property and regulatory landscape to bring products to market. Responsibilities included licensing transactions, mergers, acquisitions, technology transfers, while building intellectual property portfolios. Also supported the development of products in the new chemical and biological entity space under NDA, Hatch-Waxman, medical devices under PMA and 510(k) processes, and generic pharmaceutical products under ANDA and 505(b)(2) submissions. EXPERIENCE: IP Portfolio Management, IP Opinions, Litigation, Reissue/Reexamination, IP Asset Sale (worth over $100 million), Contract Negotiations, Settlements, Licensing, New Business Development, Collaboration Management, Team Member FDA Plant Compliance, Audit and Response, Process Plant SOP Development, API sourcing, Logistics Compliance, Import/Export Compliance, DEA Manufacturing and Compliance, M&A, New Business Venture Review Leader, People Management, Strategic Business Leader.

Elan Drug Technologies (sold to Alkermes) provided drug delivery using proprietary technologies (oral controlled release and nanocrystal formulation technologies) in partnership with pharmaceutical companies to develop new and innovative products. Developed, designed and led the US IP operations and managed the contract function. The department supported IP portfolio development and management, patent licensing, deal support, IP litigation, deal support, Hatch-Waxman and BLA guidance, IP, know-how and trade secret related protection, technology transfer management, and other IP related matters.EXPERIENCE: Management, Senior Leadership, Business Development, Technology Transactions, Due Diligence, Litigation (ANDA and other), Site Leadership and Management, Hatch-Waxman, ANDA, 505(b)(2) submissions, M&A integration management, and Corporate Integrity Agreement Implementation.

Largest global privately held pharmaceutical company. Managed the IP and FDA regulatory (including exclusivities and new market opportunities) strategy and portfolio for the multi-billion dollar block buster drug, SPIRIVA®. Supported due diligence and acquisition of new chemical and biological entities, joint-collaboration research and development, and licensing. EXPERIENCE: R&D, Biologics, Small Molecule Chemistry, Hatch-Waxman, Technology Transactions, Business Development and Management.

Patent examiner for the US government within the patent and trademark office. Searched, reviewed, and assessed the patentability of patent applications in the small molecule, formulation, and related methods of use space.EXPERIENCE: Small Molecule Chemistry, Formulation Technology, Patent Law, International Patent Law, Patent Cooperation Treaty, Training and Managing Junior Examiners.

Global leader in specialty chemicals, minerals-based synthetic products and related systems and services. Supported the patent department by attending to projects, such as IP portfolio assessment and monetization. EXPERIENCE: IP portfolio management, licensing, and patent asset valuation and monetization.